Residual striatal dopaminergic nerve terminals in very long-standing Parkinson's disease: A single photon emission computed tomography imaging study

Movement Disorders

Volumn 26, Issue 2, 2011, Pages 327-330

  Djaldetti, Ruth ^a   Lorberboym, Mordechai ^b   Karmon, Yuval ^c   Treves, Therese A ^a   Ziv, Ilan ^a   Melamed, Eldad ^a,d  

^a RABIN MEDICAL CENTER   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Dopamine transporters scan; Long standing; Parkinson's disease; Single photon emission computed tomography

Indexed keywords

FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA(4 IODOPHENYL)TROPHANE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG BINDING; DRUG UPTAKE; FEMALE; HUMAN; MALE; NERVE CELL DEGENERATION; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; BRAIN; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE ENDINGS; NEURONS; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79952672042     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23380     Document Type: Article

References (19)

1. Hely MA, Morris JG, Reid WG, Trafficante R. Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005; 20: 190-199.
2. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23: 837-844.
3. Morrish PK, Sawle GV, Brooks DJ. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 1996; 119: 585-591.
4. Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 1998; 64: 314-319.
5. Pirker W, Holler I, Gerschlager W, Asenbaum S, Zettinig G, Brücke T. Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT. Mov Disord 2003; 18: 1266-1272.
6. Marek K, Innis R, van Dyck C, et al. [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology 2001; 57: 2089-2094.
7. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
8. Lee CS, Schulzer M, de la Fuente-Fernández R, et al. Lack of regional selectivity during the progression of Parkinson disease. Arch Neurol 2004; 61: 1920-1925.
9. Nandhagopal R, Kuramoto L, Schulzer M, et al. Longitudinal progression of Parkinson's disease: a multi-tracer positron emission tomography study. Brain 2009; 132: 2970-2979.
10. Hilker R, Schweitzer K, Coburger S, et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol 2005; 62: 378-382.
11. Brück A, Aalto S, Rauhala E, Bergman J, Marttila R, Rinne JO. A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen. Mov Disord 2009; 24: 1009-1015.
12. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114(Pt 5): 2283-2301.
13. German DC, Manaye K, Smith WK, Woodward DJ, Saper CB. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol 1989; 26: 507-514.
14. Hontanilla B, de las Heras S, Giménez-Amaya JM. A topographic re-evaluation of the nigrostriatal projections to the caudate nucleus in the cat with multiple retrograde tracers. Neuroscience 1996; 72: 485-503.
15. Szabo J. Organization of the ascending striatal afferents in monkeys. J Comp Neurol 1980; 189: 307-321.
16. Hedreen JC, DeLong MR. Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque. J Comp Neurol 1991; 304: 569-595.
17. Desban M, Gauchy C, Glowinski J, Kemel ML. Heterogeneous topographical distribution of the striatonigral and striatopallidal neurons in the matrix compartment of the cat caudate nucleus. J Comp Neurol 1995; 352: 117-133.
18. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988; 318: 876-880.
19. Djaldetti R, Ziv I, Melamed E. The mystery of motor asymmetry in Parkinson's disease. Lancet Neurol 2006; 5: 796-802.